INVESTIOGATIONAL BIOLOGIC TREATMENT FOR NASAL POLYPS
WAYPOINT NASAL POLYP
We are doing this study to learn more about the effect and safety of Tezepelumab when given to patients with severe chronic rhinosinusitis with nasal polyposis (NP) and also to better understand the studied disease and associated health problems.
INVESTIOGATIONAL DEVICE FOR TREATMENT OF CHRONIC RHINITIS
The objective of this study is to evaluate the safety and efficacy of the NEUROMARK™ system, an investigational medical device manufactured by Neurent Medical. The system is designed to address symptoms related to Chronic Rhinitis (reoccurring stuffy and/or runny nose). The focus of this study is to evaluate if the procedure is safe for humans and if the device can improve your nasal symptoms. The delivery of energy is aimed to interrupt nerves that affect mucus (snot) production.
BIOLOGIC TREATMENT FOR ALLERGIC FUNGAL RHINOSINUSITIS
The purpose of the study is to evaluate how safe and effective the investigational study drug, dupilumab, is in reducing signs and symptoms in patients with AFRS.